Mirum Pharmaceuticals (MIRM) Tax Provisions (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Tax Provisions of $475000.0 for Q1 2026, down 53.84% year-over-year from $1.0 million in Q1 2025, and down 38.07% quarter-over-quarter from $767000.0 in Q4 2025.
Mirum Pharmaceuticals (MIRM) Tax Provisions (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Tax Provisions history runs 8 years deep, the most recent figure standing at $475000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 53.84% year-over-year to $475000.0; the TTM figure through Mar 2026 stood at $1.4 million (down 3.69% YoY), while the FY2025 annual figure was $1.9 million, up 87.96% from the prior year.
- Tax Provisions for Q1 2026 stood at $475000.0, down from $767000.0 in the prior quarter.
- The five-year high for Tax Provisions was $1.0 million in Q1 2025, with the low at -$6.6 million in Q2 2022.
- The 5-year median for Tax Provisions is $249000.0 (2023), against an average of -$116117.6.
- The sharpest annual moves came in 2022 and 2023: Tax Provisions sank 59827.27% in 2022, then surged 1815.38% in 2023.
- Mirum Pharmaceuticals' Tax Provisions stood at $140000.0 in 2022, then jumped by 60.71% to $225000.0 in 2023, then plunged by 356.0% to -$576000.0 in 2024, then surged by 233.16% to $767000.0 in 2025, then slumped by 38.07% to $475000.0 in 2026.
- Business Quant data shows MIRM's Tax Provisions at $475000.0 in Q1 2026, $767000.0 in Q4 2025, and -$262000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | 1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.69 Mn |
| Mar 31, 2026 | 475,000.00 |
| Dec 31, 2025 | 767,000.00 |
| Sep 30, 2025 | -262,000.00 |
| Jun 30, 2025 | 402,000.00 |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | -576,000.00 |
| Sep 30, 2024 | 347,000.00 |
| Jun 30, 2024 | 635,000.00 |
| Mar 31, 2024 | 624,000.00 |
| Dec 31, 2023 | 225,000.00 |
| Sep 30, 2023 | 249,000.00 |
| Jun 30, 2023 | 316,000.00 |
| Mar 31, 2023 | 201,000.00 |
| Dec 31, 2022 | 140,000.00 |
| Sep 30, 2022 | 13,000.00 |
| Jun 30, 2022 | -6.57 Mn |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | 9,000.00 |